Retraction: Alpha-Fetoprotein Promoter-Driven Cre/LoxP-Switched RNA Interference for Hepatocellular Carcinoma Tissue-Specific Target Therapy
Format: | Article |
---|---|
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697611/?tool=EBI |
Similar Items
-
Retraction: Alpha-Fetoprotein Promoter-Driven Cre/LoxP-Switched RNA Interference for Hepatocellular Carcinoma Tissue-Specific Target Therapy.
by: PLOS ONE Editors
Published: (2023-01-01) -
CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system
by: Dominique J. Laster, et al.
Published: (2023-08-01) -
Capturing reaction paths and intermediates in Cre-loxP recombination using single-molecule fluorescence.
by: Pinkney, J, et al.
Published: (2012) -
Evaluation of a library of loxP variants with a wide range of recombination efficiencies by Cre.
by: Yuji Yamauchi, et al.
Published: (2022-01-01) -
Utilizing the LoxP-Stop-LoxP System to Control Transgenic ABC-Transporter Expression In Vitro
by: Ikechukwu Esobi, et al.
Published: (2022-05-01)